A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
BACKGROUND: Plasmodium falciparum merozoite surface protein 3 is a malaria vaccine candidate that was identified, characterised, and developed based on a unique immuno-clinical approach. The vaccine construct was derived from regions fully conserved among various strains and containing B cell epitop...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2005-11-01
|
| Series: | PLoS Medicine |
| Online Access: | http://dx.doi.org/10.1371/journal.pmed.0020344 |